Abstract
Background: The World Health Organization (WHO) criteria for the diagnosis of acute myocardial infarction (AMI) includes presentation of chest pain over 20 min, evolutionary changes on the electrocardiogram (ECG), and abnormal levels of cardiac enzymes.
Hypothesis: A multicenter study was conducted to evaluate the efficacy of cardiac troponin I (cTnI) in detecting and ruling out AMI.
Methods: The normal range for cTnI in 149 apparently healthy subjects without known history of cardiac or other diseases was 0 to 0.5 ng/ml. Cutoffs of 2.5 ng/ml for cTnI and 5.0 ng/ml for creatine kinase‐MB (CK‐MB) were used.
Results: The diagnostic sensitivity of blood collected from 291 consecutive patients with suspicion of AMI was 95.0 and 96.4%, respectively, for samples obtained at 4–48 h after AMI onset. CK‐MB was more sensitive during the early 4–8 h interval (84 vs. 74%); both had 100% sensitivity from 12–36 h. CTnI remained at 100% for 72 h, while CK‐MB declined to 57%. The clinical specificity was 97.4 vs. 85.8%, respectively, on non‐AMI patients with cardiac and noncardiac diseases, and those with renal disease.
Conclusion: cTnI is an excellent marker for detecting and ruling out AMI, because it has better specificity and a wider diagnostic window than the accepted standard, CK‐MB.
Keywords: acute myocardial infarction, cardiac troponin I, creatine kinase
Full Text
The Full Text of this article is available as a PDF (321.4 KB).
References
- 1. World Health Organization : Report of the Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 1979; 59: 607–609. [DOI] [PubMed] [Google Scholar]
- 2. Wu AHB, Gornet TG, Bretaudiere JP, Panfili PR: Comparison of enzyme immunoassay and immunoinhibition for creatine kinase MB in diagnosis of acute myocardial infarction. Clin Chem 1985; 31: 470–474. [PubMed] [Google Scholar]
- 3. Chan KM, Ladenson JH, Pierce GF, Jaffe AS: Increased creatine kinase in the absence of acute myocardial infarction (Washington University Case Conference). Clin Chem 1986; 32: 2044–2051. [PubMed] [Google Scholar]
- 4. Kiessling WR, Ricker K, Pflughaupt KW, Mertens HG, Haubitz I: Serum myoglobin in primary and secondary skeletal muscle disorders. J Neurol 1981; 224: 229–233. [DOI] [PubMed] [Google Scholar]
- 5. Adams JE, Bodor GS, Davaila‐Roman VG, Delmez JA, Apple FS, Ladenson JH, Jaffee AS: Cardiac troponin I: A marker with high specificity for cardiac injury. Circulation 1993; 88: 101–106. [DOI] [PubMed] [Google Scholar]
- 6. Wilkinson JM, Grand RJA: Comparison of amino acid sequence of troponin I from striated muscles. Nature 1978; 27: 31–35. [DOI] [PubMed] [Google Scholar]
- 7. Larue C, Defacque‐Lacquement H, Calzolari C, Nguyen DL, Pau B: New monoclonal antibodies as probes for human cardiac troponin I: Epitope analysis with synthetic peptides. Mol Immunol 1992; 29: 271–278. [DOI] [PubMed] [Google Scholar]
- 8. Henderson AR, Bhayana V: A modest proposal for the consistent presentation of ROC plots in Clinical Chemistry. Clin Chem 1995; 41: 1205–1206. [PubMed] [Google Scholar]
- 9. Hafner G, Thome‐Kromer B, Schaube J, Kupferwasser I, Ehrenthal W, Cumins P, Prellwitz W, Michel G: Cardiac troponins in serum in chronic renal failure. Clin Chem 1994; 40: 1790–1791. [PubMed] [Google Scholar]
- 10. Bodor GS, Porterfield D, Voss EM, Smith S, Apple F: Cardiac troponin‐T is not expressed in fetal and healthy or diseased human skeletal muscle tissue. Clin Chem 1995; 41: 1710–1715. [PubMed] [Google Scholar]
- 11. Ohman EM, Armstrong PW, Christenson RH, Granger CB, Katus HA, Hamm CW, O'Hanesian MA, Wagner GS, Kleiman NS, Harrell FE, Califf RM, Topol EJ: Cardiac troponin T levels for risk stratification in acute myocardial ischemia. N Engl J Med 1996; 335: 1333–1341. [DOI] [PubMed] [Google Scholar]
- 12. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, Fischer GA, Fung AY, Thompson C, Wybenga D, Braunwald E: Cardiac‐specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996; 335: 1342–1349. [DOI] [PubMed] [Google Scholar]